Accutest’s bioanalytical team possesses specialized expertise in the analysis of chiral molecules, enantiomers, and positional isomers an area that requires advanced chromatographic techniques, precise method development, and deep scientific understanding. Chiral separation is often a regulatory requirement for many drugs, given that enantiomers can differ significantly in pharmacokinetics and pharmacodynamics. Our laboratory has successfully executed chiral LC MS/MS assays across a wide range of therapeutic areas.

Our team excels in addressing complex challenges such as:

• Development of robust chiral chromatographic methods
• Separation of closely related isomers with minimal interference
• Accurate quantification of each enantiomer under stringent sensitivity requirements
• Ensuring stability and reproducibility across long analytical runs
• Compliance with global regulatory expectations for chiral drugs
• Managing shifts in enantiomer interconversion or degradation

This expertise ensures that sponsors receive high quality, defensible data for regulatory filings in global markets.

• Deep expertise in multi analyte and multi metabolite quantification
• Proven success across the most challenging therapeutic classes
• Large scientific team with decades of method development experience
• High throughput operations that safeguard project timelines
• Reliable, reproducible data that withstand global regulatory scrutiny
• Your Trusted Partner for Complex Bioanalysis
  
  Accutest delivers high quality bioanalytical solutions for even the most demanding studies helping sponsors accelerate approvals while maintaining scientific excellence.